Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Dual role of chloroquine in liver ischemia reperfusion injury: reduction of liver damage in early phase, but aggravation in late phase.

Fang H, Liu A, Dahmen U, Dirsch O.

Cell Death Dis. 2013 Jun 27;4:e694. doi: 10.1038/cddis.2013.225.

2.

The fibrin-derived peptide bβ15-42 attenuates liver damage in a rat model of liver ischemia/reperfusion injury.

Liu A, Fang H, Yang Y, Sun J, Fan H, Liu S, Dirsch O, Dahmen U.

Shock. 2013 Apr;39(4):397-403. doi: 10.1097/SHK.0b013e31828c2b75.

PMID:
23503399
3.

7,8-dihydroxycoumarin has a dual mechanism of action in hepatic ischemia reperfusion injury.

Zhu HY, Gao HW, Zhang SF.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):10121-9. eCollection 2015.

4.

HMGB1 translocation and expression is caused by warm ischemia reperfusion injury, but not by partial hepatectomy in rats.

Liu A, Dirsch O, Fang H, Dong W, Jin H, Huang H, Sun J, Dahmen U.

Exp Mol Pathol. 2011 Oct;91(2):502-8. doi: 10.1016/j.yexmp.2011.05.005. Epub 2011 May 27.

PMID:
21640719
5.

The role of AKT1 and autophagy in the protective effect of hydrogen sulphide against hepatic ischemia/reperfusion injury in mice.

Wang D, Ma Y, Li Z, Kang K, Sun X, Pan S, Wang J, Pan H, Liu L, Liang D, Jiang H.

Autophagy. 2012 Jun;8(6):954-62. doi: 10.4161/auto.19927. Epub 2012 Jun 1.

6.

Chronic lithium treatment protects against liver ischemia/reperfusion injury in rats.

Liu A, Fang H, Dahmen U, Dirsch O.

Liver Transpl. 2013 Jul;19(7):762-72. doi: 10.1002/lt.23666.

7.

Ischemic preconditioning protects against liver ischemia/reperfusion injury via heme oxygenase-1-mediated autophagy.

Liu A, Fang H, Wei W, Dirsch O, Dahmen U.

Crit Care Med. 2014 Dec;42(12):e762-71. doi: 10.1097/CCM.0000000000000659.

PMID:
25402296
8.

HMGB1 in ischemic and non-ischemic liver after selective warm ischemia/reperfusion in rat.

Liu A, Dirsch O, Fang H, Sun J, Jin H, Dong W, Dahmen U.

Histochem Cell Biol. 2011 May;135(5):443-52. doi: 10.1007/s00418-011-0802-6. Epub 2011 Mar 24.

PMID:
21431875
9.

The effect of octreotide on hepatic ischemia-reperfusion injury in a rabbit model.

Yang J, Sun H, Takacs P, Zhang Y, Liu J, Chang Y, Candiotti KA.

Transplant Proc. 2013 Jul-Aug;45(6):2433-8. doi: 10.1016/j.transproceed.2013.02.112.

PMID:
23953560
10.

Dietary omega-3 polyunsaturated fatty acids attenuate hepatic ischemia/reperfusion injury in rats by modulating toll-like receptor recruitment into lipid rafts.

Kim K, Jung N, Lee K, Choi J, Kim S, Jun J, Kim E, Kim D.

Clin Nutr. 2013 Oct;32(5):855-62. doi: 10.1016/j.clnu.2012.11.026. Epub 2013 Jan 23.

PMID:
23395256
11.

Cisplatin prevents high mobility group box 1 release and is protective in a murine model of hepatic ischemia/reperfusion injury.

Cardinal J, Pan P, Dhupar R, Ross M, Nakao A, Lotze M, Billiar T, Geller D, Tsung A.

Hepatology. 2009 Aug;50(2):565-74. doi: 10.1002/hep.23021.

PMID:
19492424
12.

Early release of macrophage migration inhibitory factor after liver ischemia and reperfusion injury in rats.

Liu A, Fang H, Dirsch O, Jin H, Dahmen U.

Cytokine. 2012 Jan;57(1):150-7. doi: 10.1016/j.cyto.2011.11.009. Epub 2011 Dec 3.

PMID:
22136975
13.

Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation.

Jiang S, Shi Z, Li C, Ma C, Bai X, Wang C.

Int J Clin Exp Pathol. 2014 Apr 15;7(5):2595-608. eCollection 2014.

14.

Vitamin E derivative ETS-GS reduces liver ischemia-reperfusion injury in rats.

Koga H, Hagiwara S, Inomata M, Kusaka J, Asai N, Oyama M, Kita K, Kashima K, Yokoi I, Noguchi T.

J Surg Res. 2012 Jun 1;175(1):118-22. doi: 10.1016/j.jss.2011.02.045. Epub 2011 Apr 9.

PMID:
21529839
15.

Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1.

Dulkanchainun TS, Goss JA, Imagawa DK, Shaw GD, Anselmo DM, Kaldas F, Wang T, Zhao D, Busuttil AA, Kato H, Murray NG, Kupiec-Weglinski JW, Busuttil RW.

Ann Surg. 1998 Jun;227(6):832-40.

16.

Ethyl pyruvate ameliorates liver ischemia-reperfusion injury by decreasing hepatic necrosis and apoptosis.

Tsung A, Kaizu T, Nakao A, Shao L, Bucher B, Fink MP, Murase N, Geller DA.

Transplantation. 2005 Jan 27;79(2):196-204.

PMID:
15665768
17.
18.

Remifentanil protects liver against ischemia/reperfusion injury through activation of anti-apoptotic pathways.

Zhao G, Shen X, Nan H, Yan L, Zhao H, Yu J, Lv Y.

J Surg Res. 2013 Aug;183(2):827-34. doi: 10.1016/j.jss.2013.02.058. Epub 2013 Mar 22.

PMID:
23608616
19.

The role of HMGB-1 on the development of necrosis during hepatic ischemia and hepatic ischemia/reperfusion injury in mice.

Watanabe T, Kubota S, Nagaya M, Ozaki S, Nagafuchi H, Akashi K, Taira Y, Tsukikawa S, Oowada S, Nakano S.

J Surg Res. 2005 Mar;124(1):59-66.

PMID:
15734480
20.

Protective effect of L-arginine against necrosis and apoptosis induced by experimental ischemic and reperfusion in rat liver.

Chattopadhyay P, Shukla G, Wahi AK.

Saudi J Gastroenterol. 2009 Jul-Sep;15(3):156-62. doi: 10.4103/1319-3767.45356.

Supplemental Content

Support Center